{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Zevra Therapeutics, Inc. "},"Symbol":{"label":"Symbol","value":"ZVRA"},"Address":{"label":"Address","value":"1180 CELEBRATION BOULEVARD,SUITE 103, CELEBRATION, Florida, 34747, United States"},"Phone":{"label":"Phone","value":"+1 321 939-3416"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older."},"CompanyUrl":{"label":"Company Url","value":"https://www.zevra.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Adrian Quartel","title":"Chief Medical Officer"},{"name":"Daniel Gallo","title":"Senior Vice President-Medical Affairs & Advocacy"},{"name":"Neil F. McFarlane","title":"President, Chief Executive Officer & Director"},{"name":"Sven Guenther","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}